Drug Shortage Report for SAXENDA

Last updated on 2024-01-03 History
Report ID 213933
Drug Identification Number 02437899
Brand name SAXENDA
Common or Proper name SAXENDA® 6 MG/ML 5X3 ML
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) LIRAGLUTIDE
Strength(s) 6MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-12-20
Actual start date 2023-12-20
Estimated end date 2024-01-05
Actual end date 2024-01-02
Shortage status Resolved
Updated date 2024-01-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-01-03 English Compare
v7 2024-01-02 French Compare
v6 2024-01-02 English Compare
v5 2023-12-21 English Compare
v4 2023-12-20 French Compare
v3 2023-12-20 English Compare
v2 2023-12-20 English Compare
v1 2023-12-20 English Compare

Showing 1 to 8 of 8